Cargando…
Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
[Image: see text] MmpL3, an essential transporter involved in the export of mycolic acids, is the proposed target of a number of antimycobacterial inhibitors under development. Whether MmpL3 serves as the direct target of these compounds, however, has been called into question after the discovery th...
Autores principales: | Li, Wei, Stevens, Casey M., Pandya, Amitkumar N., Darzynkiewicz, Zbigniew, Bhattarai, Pankaj, Tong, Weiwei, Gonzalez-Juarrero, Mercedes, North, E. Jeffrey, Zgurskaya, Helen I., Jackson, Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580365/ https://www.ncbi.nlm.nih.gov/pubmed/30882198 http://dx.doi.org/10.1021/acsinfecdis.9b00048 |
Ejemplares similares
-
Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds In Vitro
por: Li, Wei, et al.
Publicado: (2017) -
Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors
por: Stevens, Casey M., et al.
Publicado: (2022) -
MmpL3 as a Target for the Treatment of Drug-Resistant Nontuberculous Mycobacterial Infections
por: Li, Wei, et al.
Publicado: (2018) -
The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria
por: Belardinelli, Juan Manuel, et al.
Publicado: (2019) -
MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections
por: Sethiya, Jigar P., et al.
Publicado: (2020)